Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice

The COVID-19 pandemic continues to threaten human health worldwide as new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerge. Currently, the predominant circulating strains around the world are Omicron variants, which can evade many therapeutic antibodies. Thus, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Ruei-Min, Liang, Kang-Hao, Chiang, Hsiao-Ling, Hsu, Fu-Fei, Lin, Hsiu-Ting, Chen, Wan-Yu, Ke, Feng-Yi, Kumari, Monika, Chou, Yu-Chi, Tao, Mi-Hua, Yi-Ling Lin, Wu, Han-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111857/
https://www.ncbi.nlm.nih.gov/pubmed/37090428
http://dx.doi.org/10.1016/j.heliyon.2023.e15587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111857/
https://www.ncbi.nlm.nih.gov/pubmed/37090428
http://dx.doi.org/10.1016/j.heliyon.2023.e15587

Ejemplares similares